Cannabis Freedom Index
← History

Hemp 🇸🇰 Slovakia

Slovakia takes CBD off its psychotropic-substance list

Cannabidiol ceased to be listed as a psychotropic substance when the amendment took effect. The law deleted the named CBD entry while leaving cannabis and THC subject to their separate controls.[1]

The story

Slovakia removed cannabidiol, or CBD, from its psychotropic-substance list on 1 May 2021.[1] Parliament’s amendment deleted the entry naming CBD, changing the substance’s position under the controlled-drug law.[1]

Parliament deleted the named substance

The National Council approved the amendment on 18 March 2021, and it was published on 9 April before taking effect in May.[1] The operative provision removed the cannabidiol entry from the second group of psychotropic substances.[1]

The amendment worked through the existing controlled-substances statute, which separately regulates authorisations, cultivation, production and handling.[1][2] Cannabis and THC remained covered by their own entries and rules.[2] For growers, the relevant permissions therefore continued to depend on the plant, variety and purpose involved.[2]

Hemp cultivation retained its own rules

The current statute permits industrial growing for obtaining fibre and seed, alongside a separate research route.[2] Varieties listed in the EU common catalogue, including varieties listed when they were sown, are exempt from the ordinary Health Ministry cultivation permit.[2]

Other cultivation and processing need permission, with safeguards against diversion.[2] A cultivation permit ordinarily lasts one year, and permit holders must hand the harvest to a processing organisation or destroy the remaining material under supervision.[2] These conditions govern how plants and harvests move through authorised production.[2]

Food and medicines followed different assessments

The Agriculture Ministry’s February 2026 notice explains that CBD is treated as a novel food under EU rules.[3] It reports EFSA’s temporary intake benchmark while emphasising gaps in the available safety evidence.[3] Food classification and safety assessment therefore remained relevant after the controlled-substance deletion.[3]

A separate 2023 NIHO assessment evaluated the purified CBD medicine Epidyolex with clobazam for Dravet and Lennox-Gastaut syndromes from age two.[4] That report considered clinical and economic evidence for a particular treatment and patient group.[4]

Later controls covered other cannabinoids

Slovakia added HHC and related cannabinoids to its drug schedules in November 2024.[5] The amendment named substances individually, including HHC, HHC-O and HHC-P.[5] It also revised authorisation and hemp-cultivation provisions within the controlled-substances law.[5]

The Slovakia profile follows these separate rules for controlled cannabis, industrial hemp, CBD and licensed research.[2][5]

In the cultural atlas

Listed for context. No score change is recorded for Slovakia here.

References

  1. Slov-Lex — Act 124/2021Article I point 32 and commencementarchived
  2. Slov-Lex — Controlled Substances Act 139/1998, January 2026 consolidationSection 15 and schedulesarchived
  3. Slovak Agriculture Ministry — CBD novel-food safety notice, 20 February 2026archived
  4. NIHO — Cannabidiol/Epidyolex assessment 37A/2023archived
  5. Slov-Lex — Act 246/2024Controlled cannabinoids and commencementarchived

Checked. The date and the event were compared with a source that was read.

    ↑↓ to move, ↵ to open.